Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.
China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.
Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.
China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.
Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.
Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.
It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.
More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.
The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.
Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.
In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.
Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.
It is learnt that the youth from minority community used to distribute sweets on the during the Independence Day procession every year. 
Comments
RSS biggest strenght is Lie. They can't digest the patriotism of muslims. Before the Independence RSS was supporting British, once got the Independence Rats started to come out. They have no moral rights to blame others on patriotism their forefathers were proved their patriotism while supporting British. Jai hind
True, Sangeeth... media always highlight muslims, minority and dalits..
Biased media. There might be some other reason. without reason why we should attack them.
LOL... Exactly Rajeev..
The reason is nothing but they distributed not saffron colour laddu.. they gave yellow laddu. nobody can tolerate this extreme step.. so they attacked
This is the outcome of Amit Shah's visit to karnataka.
Why amicable settlement grab such desh drohi culprit and make a procession let the peace loving Mangaloreans aware of such bjp wings lntention and motive.
Spreading communalism not required in our south kanara dist.
Add new comment